Emergency Department-Based Treatment of Acute Ureteral Colic with Hydromorphone and Pethidine: Prospective, Randomized Control Trial
Journal of the Korean Society of Emergency Medicine
; : 151-155, 2011.
Article
em Ko
| WPRIM
| ID: wpr-160067
Biblioteca responsável:
WPRO
ABSTRACT
PURPOSE: To compare the efficacies and side effects of intravenous hydromorphone and pethidine in the emergency department (ED) treatment of ureteral colic. METHODS: A prospective, controlled, randomized clinical trial was conducted in a university-affiliated tertiary referral center. All adult patients who presented to the ED with severe ureteral colic were included. The patients received either 1 mg of hydromorphone (n=26) or 50 mg of pethidine (n=26) intravenously. Pain intensity was determined using a 10 cm visual analogue scale 0, 15, 30, and 120 minutes after injection. RESULTS: Dermographic characteristics and baseline pain scores of both groups were comparable (p>0.05). The pain intensity level for the hydromorphone group was lower than for the pethidine group at 15, 30, and 120 minutes. Pain relief was better with hydromorphone at 15 minutes (p<0.05). Side effects of the two groups were not statistically significant. CONCLUSION: The ureteral colic patients receiving hydromorphone achieved more pain relief. The side effects were similar for either treatment. Hydromorphone should be the preferred agent in suspected ureteral colic, when an opioid analgesic is to be used.
Palavras-chave
Texto completo:
1
Base de dados:
WPRIM
Assunto principal:
Piperidonas
/
Ureter
/
Estudos Prospectivos
/
Benzenoacetamidas
/
Hidromorfona
/
Emergências
/
Cólica Renal
/
Centros de Atenção Terciária
/
Meperidina
Tipo de estudo:
Clinical_trials
/
Observational_studies
Limite:
Adult
/
Humans
Idioma:
Ko
Ano de publicação:
2011
Tipo de documento:
Article